Literature DB >> 4168247

Cyclophosphamide in the treatment of myelomatosis.

O S Choi, A English, J H Hilton, G E Catton, M D Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4168247      PMCID: PMC1923556     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  MULTIPLE MYELOMA. II. ANALYSIS OF CYCLOPHOSPHAMIDE THERAPY IN 165 PATIENTS.

Authors:  D R KORST; G O CLIFFORD; W M FOWLER; J LOUIS; J WILL; H E WILSON
Journal:  JAMA       Date:  1964-09-07       Impact factor: 56.272

2.  Comparison of effect of cyclophosphamide and a placebo in treatment of multiple myeloma.

Authors:  S L RIVERS; R M WHITTINGTON; M E PATNO
Journal:  Cancer Chemother Rep       Date:  1963-05

3.  Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors.

Authors:  R L WALL; F G CONRAD
Journal:  Arch Intern Med       Date:  1961-09

4.  Plasma-cell myeloma. II. Clinical aspects.

Authors:  E F OSSERMAN
Journal:  N Engl J Med       Date:  1959-11-05       Impact factor: 91.245

5.  Cyclophosphamide in Hodgkin's disease and related disorders.

Authors:  J Q MATTHIAS; J J MISIEWICZ; R B SCOTT
Journal:  Br Med J       Date:  1960-12-24

6.  Cyclophosphamide. A preliminary study of a new alkylating agent.

Authors:  L V FOYE; C G CHAPMAN; F M WILLETT; W S ADAMS
Journal:  Cancer Chemother Rep       Date:  1960-02

7.  A prelusive clinical trial of cyclophosphamide.

Authors:  D E BERGSAGEL; W C LEVIN
Journal:  Cancer Chemother Rep       Date:  1960-07

8.  Preliminary studies with cyclophosphamide.

Authors:  B I SHNIDER
Journal:  Cancer Chemother Rep       Date:  1960-07

9.  MULTIPLE MYELOMA. STUDIES OF MOUSE PLASMA CELL TUMOR AND HUMAN MYELOMA RESPONSIVENESS TO CYCLOPHOSPHAMIDE (CYTOXAN).

Authors:  D R KORST; E P FRENKEL; J C NIXON
Journal:  Ann Intern Med       Date:  1964-02       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.